Healthcare Provisions In The American Taxpayer Relief Act - The Good, The Bad And The Ugly

by BakerHostetler

In late night action on December 31, 2012, the American Taxpayer Relief Act of 2012 (ATRA) was passed by the Senate and finalized days later by Congress and the President with a set of tax and spending policy provisions intended to provide relief to the American taxpayer -- avoiding the "fiscal cliff" set up by the Budget Control Act of 2011. Upon closer inspection, however, the ATRA also has some important implications for the healthcare industry and sets the stage for future healthcare spending reductions and appropriations discussions in 2013. The following offers a brief overview of the ATRA's good, bad and ugly provisions for the healthcare industry.

The Good

One of the largest issues looming over Congress relating to Medicare involved the fate of the sustainable growth rate (SGR) impending statutory cuts of nearly 27 percent, which would have further exacerbated the physician shortage currently experienced in the Medicare program and was widely criticized. The ATRA addressed this issue, but once again, only did so for a short time. At a cost of $25 billion, the ATRA froze existing Medicare physician rates at their current level through 2013. This means that the SGR fight to obtain permanent relief will continue during 2013.

The impending Budget Control Act sequester which would have included a mandatory two percent Medicare provider rate cut, reductions in important discretionary spending programs such as the National Institutes of Health (NIH) and graduate medical education programs is delayed for two months.

Other Medicare reimbursement and healthcare programs set to expire on December 31, 2012, were extended, including the Medicare physician work geographic adjustment and certain Medicare programs necessary to sustain ambulance service and Medicare dependent individuals in rural areas. Medicare payment changes for outpatient therapy services at hospitals were also addressed.

Funding for low-income outreach and assistance programs and the Medicaid qualified individual and transitional assistance programs were extended. Similarly, the ATRA reauthorized the Medicaid and Children's Health Insurance Program express lane option program through September 30, 2014.

The Bad

Generally, the major issues that hung in the balance with regard to healthcare spending during last year's fiscal cliff negotiations remain unresolved, and the ATRA added upwards of $4 trillion to the deficit over the next ten years. As Congress continues to grapple with the nation's fiscal woes in the coming months, spending reductions in healthcare remain in the crosshairs.

Medicaid disproportionate share hospital (DSH) payments will be rebased to extend the anticipated Affordable Care Act (ACA) reductions from 2021 to 2022. The rebasing of DSH payments is expected to provide up to $4.2 billion in savings over ten years.

Bundled payments for end stage renal disease will be rebased. Incorporating recommendations from a General Accounting Office report relating to reductions in oral drugs and biologics, the payment reduction for renal dialysis services is anticipated to achieve $4.9 billion in savings.

The ATRA rescinds unobligated funds for the ACA's Consumer Operated and Oriented Plan (CO-OP) program to the tune of approximately $2.3 billion.

Also as discussed in detail in the article that follows, the ATRA significantly alters provider rights related to overpayment recoupment, refunds, audits and claims appeals.

The Ugly

Overall healthcare industry spending continues under the microscope and, as Congress prepares over the next several months to make significant headway on cost reductions, entitlement reform will rank high on the nation's agenda. Consequently, Medicare, Medicaid, discretionary programs, research and graduate medical education all will be targets for spending reductions. Creative solutions to save money and continue coverage for individuals will be sorely needed. Providers will want to be at the table to ensure that provider reimbursement, the first at the chopping block, will not be the sole mechanism that Congress employs to reduce healthcare spending in the budget battles ahead.

BakerHostetler remains committed to working with providers to ensure that their strategic initiatives are conveyed on Capitol Hill and that their issues are heard. For more information regarding our healthcare policy practice or relating to the ATRA and its impact, please contact Susan Feigin Harris, or 713.646.1307, or Kathleen P. Rubinstein, MPA, Policy Analyst, or 713.276.1650.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© BakerHostetler | Attorney Advertising

Written by:


BakerHostetler on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.